Catch up on today’s top five analyst downgrades with this list compiled by The Fly: 1. Cummins (CMI) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revich saying U.S. and China truck demand is set to slow. 2. Oshkosh (OSK) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Jerry Revich saying supply chain headwinds drives his near-term estimates below consensus, while the delayed analyst day “limits the near-term catalyst path.” 3. Theravance Biopharma (TBPH) downgraded to Market Perform from Outperform at Cowen with analyst Marc Frahm saying following last night’s failure in ulcerative colitis, izencitinib “appears to have little future.” 4. Victoria’s Secret (VSCO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Kimberly Greenberger seeing limited potential for further share gains following the stock’s “significant outperformance.” 5. Genmab (GMAB) downgraded to Neutral from Buy at H.C. Wainwright with analyst Raghuram Selvaraju believing the current share price appropriately reflects the value of the company’s commercial-stage portfolio, as well as its late-stage clinical pipeline. This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post
next post